Literature DB >> 29273143

Get with the Program! Stemness and Reprogramming in Melanoma Metastasis.

Fernanda Faião-Flores1, Keiran S M Smalley2.   

Abstract

Cancer cells are highly plastic and adopt multiple phenotypic states that contribute to tumor progression. Heppt et al. demonstrate that the homeodomain transcription factor Msh homeobox 1 reprograms melanoma cells to a precursor state associated with melanoma progression and increased liver metastasis. Identification of this new role for Msh homeobox 1 may facilitate the development of new therapies that limit melanoma dissemination.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29273143     DOI: 10.1016/j.jid.2017.07.001

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

1.  Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma.

Authors:  Hongjie Shi; Linzhi Han; Jinping Zhao; Kaijie Wang; Ming Xu; Jiajun Shi; Zhe Dong
Journal:  Cancer Med       Date:  2021-11-05       Impact factor: 4.452

2.  An Integrative Analysis of The Micro-RNAs Contributing in Stemness, Metastasis and B-Raf Pathways in Malignant Melanoma and Melanoma Stem Cell.

Authors:  Parisa Sahranavardfard; Zahra Madjd; Amir Nader Emami Razavi; Ali Reza Ghanadan; Javad Firouzi; Pardis Khosravani; Saeid Ghavami; Esmaeil Ebrahimie; Marzieh Ebrahimi
Journal:  Cell J       Date:  2021-07-17       Impact factor: 2.479

Review 3.  Cutaneous Melanoma-A Long Road from Experimental Models to Clinical Outcome: A Review.

Authors:  Dorina Coricovac; Cristina Dehelean; Elena-Alina Moaca; Iulia Pinzaru; Tiberiu Bratu; Dan Navolan; Ovidiu Boruga
Journal:  Int J Mol Sci       Date:  2018-05-24       Impact factor: 5.923

4.  Single-Cell RNA Sequencing Unravels Heterogeneity of the Stromal Niche in Cutaneous Melanoma Heterogeneous Spheroids.

Authors:  Jiří Novotný; Karolína Strnadová; Barbora Dvořánková; Šárka Kocourková; Radek Jakša; Pavel Dundr; Václav Pačes; Karel Smetana; Michal Kolář; Lukáš Lacina
Journal:  Cancers (Basel)       Date:  2020-11-10       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.